Automated characterization of infantile spasms
Official title: Characterization by Automated System on Infantile Spasmes
Run by Assistance Publique - Hôpitaux de Paris · NCT06266234 · Data updated 2026-11-12
This study is testing a new automated system to help doctors better identify and treat infantile spasms in babies to improve their development and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 3 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Garches) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT06266234 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants who have presented with spasms and have undergone video EEG recording.
✕Probably not a fit
Patients who do not have a diagnosis of infantile spasms or have not undergone video EEG recording may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on infantile spasms, a serious form of epilepsy characterized by brief, specific motor seizures. The study aims to improve early identification and treatment of these spasms, which can lead to significant developmental delays if not addressed promptly. By utilizing automated systems for characterization, the study seeks to enhance diagnostic accuracy and treatment outcomes for affected infants. Participants will include patients who have experienced spasms and undergone video EEG recording at participating centers.
Why it matters
Potential benefit: If successful, this study could lead to improved early diagnosis and treatment of infantile spasms, potentially enhancing long-term developmental outcomes for affected infants.
How similar studies have gone: While there is ongoing research into the treatment of infantile spasms, this specific approach utilizing automated characterization is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who presented with spasm and had a video EEG recording in one of the participating centers * Social security affiliation * Legal tutor autorisation. Exclusion Criteria: \-
Where it's running
-
Department of paediatric neurological care and intensive care unity (PICU), Raymond Poincaré hospital - APHP
Garches, France Recruiting
Study contacts
- Principal investigator: Jean Bergounioux, MD, PhD — Department of paediatric neurological care and intensive care unity, Raymond Poincaré hospital - APHP
- Study coordinator: Samuel Diop, PhD
- Email: snfdiop@outlook.com
- Phone: + 33 1 47 10 79 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining vigabatrin and high dose prednisolone for treating infantile spasms
This study is testing if combining vigabatrin with high doses of prednisolone can help infants with infantile spasms feel better compared to using vigabatrin alone.
-
Treatment for infantile spasms using fenfluramine
This study is testing if a medication called fenfluramine can help young children with hard-to-treat infantile spasms feel better and have fewer seizures.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.